REG - Transense Technlgy - Director/PDMR shareholding – acquisition of shares

Transense TechnologiesAnnouncement

08/01/2025 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250108:nRSH6220Sa&default-theme=true

RNS Number : 6220S  Transense Technologies PLC  08 January 2025

8 January 2025

Transense Technologies plc

("Transense" or the "Company")

 

Director/PDMR shareholding - acquisition of shares

 

Transense Technologies plc (AIM:TRT), the provider of specialist sensing
solutions and measurement systems, has been notified that today, 8 January
2025, Ryan Maughan, Managing Director, purchased 3,025 ordinary shares of 10
pence each in the Company ("Ordinary Shares") at 165 pence per share.

 

Accordingly, Ryan Maughan's total beneficial shareholding in the Company has
increased to 72,981 Ordinary Shares, which represents approximately 0.48% of
the Company's current voting rights.

 

Further details are provided in the form below in accordance with the
requirements of the UK Market Abuse Regulation.

 

For further information please visit www.transense.com or contact:

 

 Transense Technologies plc                                     Via Investor Relations

 Nigel Rogers (Executive Chairman)                              (see below)

 Ryan Maughan (Managing Director)

 Melvyn Segal (Chief Financial Officer)
 Allenby Capital (Nominated Adviser and Broker)                 Tel: +44 (0)20 3328 5656

 Jeremy Porter / George Payne (Corporate Finance)

 Stefano Aquilino / Tony Quirke (Sales and Corporate Broking)
 Investor Relations                                             Tel: +44 (0)1869 238380 investor.relations@transense.co.uk

                                                              (mailto:investor.relations@transense.co.uk)
 Anice McNamee

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on
AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company
develops and supplies advanced sensor technology and measurement solutions
used by some of the world's leading companies to improve performance,
efficiency, and safety in demanding, mission critical applications. Transense
currently operates through two active business segments:

 

·    SAWsense - designs, supplies and licences advanced sensor solutions
based on proven, patent protected Surface Acoustic Wave (SAW) technology to
world leading companies in aerospace, automotive, and industrial machinery
(including robotics), enabling improved efficiency and performance of their
products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied,
Airbus and several other confidential Tier One automotive, aerospace and
industrial machinery suppliers.

 

·    Translogik - develops smart, connected commercial vehicle tyre
inspection equipment to many of the world's leading tyre suppliers, fleet
operators and service centres. Enabling accurate measurement and digital
capture of safety-critical tyre condition data, used to reduce operating
costs, improve safety and provide audit records for regulatory compliance. Key
customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli),
and leading independent providers of vehicle fleet maintenance management
software.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack -
a tyre monitoring system for off-highway vehicles that was developed by
Translogik. The associated sales, support and development infrastructure were
sold to Bridgestone Corporation, the world's largest tyre producer, in June
2020, and the intellectual property was licensed exclusively to Bridgestone
under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/ (https://www.transense.com/)

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Ryan Maughan

 2    Reason for the notification

 a)   Position/status                                              Managing Director

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Transense Technologies plc

 b)   LEI                                                          2138005N52J6KKQ3EY67

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 10 pence each

      Identification code                                          GB00BDHDTH21

 b)   Nature of the transaction                                    Purchase of Ordinary Shares

 c)   Price and volume                                             Price(s)   Volume(s)
                                                                   165 pence  3,025

 d)   Aggregated information

      - Aggregated volume                                          As above
      - Price

 e)   Date of the transaction                                      8 January 2025

 f)   Place of the transaction                                     London Stock Exchange, AIM

d)

 

Aggregated information

- Aggregated volume

As above

- Price

e)

 

Date of the transaction

 

8 January 2025

f)

 

Place of the transaction

 

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUPUUAGUPAGWR